Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting. [electronic resource]
- Expert review of anticancer therapy Oct 2004
- 715-24 p. digital
Publication Type: Journal Article; Review
1744-8328
10.1586/14737140.4.5.715 doi
Adolescent Adult Aged Antiemetics--therapeutic use Antineoplastic Agents--adverse effects Aprepitant Clinical Trials as Topic Female Humans Male Middle Aged Morpholines--therapeutic use Nausea--chemically induced Risk Factors Vomiting--chemically induced